Cardiff University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cardiff University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011826
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of engineering and physical sciences, bio-medical and life sciences, and arts, humanities, and social sciences. Cardiff University offers courses in various disciplines including accounting, history, language, archaeology, architecture, astrophysics, banking and finance, biology, bio-medical science, biotechnology, business management, chemistry, civil engineering, computer science, criminology, dentistry, ecology, environment, geology, and others. The institute operates in Cardiff and Wales, the UK. Cardiff University is headquartered in Cardiff, the UK.

Cardiff University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cardiff University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Diamyd Medical Enters into Partnership with Cardiff University 10
Licensing Agreements 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University – Key Competitors 14
Cardiff University – Key Employees 15
Cardiff University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Government and Public Interest 18
Nov 17, 2017: Improved method of engineering T-cells to attack cancer 18
Aug 31, 2016: Potential New Treatment for Cocaine Addiction 19
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 20
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 21
May 05, 2016: Drug combination could help reduce risk of death in type 2 diabetes 22
Jan 13, 2016: Upgrading the immune system : Cardiff University 23
Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cardiff University, Pharmaceuticals & Healthcare, Key Facts 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Diamyd Medical Enters into Partnership with Cardiff University 10
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University, Key Competitors 14
Cardiff University, Key Employees 15
Cardiff University, Other Locations 16
Cardiff University, Subsidiaries 17

★海外企業調査レポート[Cardiff University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務情報
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Intercept Energy Services Inc. (IES):企業概要、財務及び戦略的SWOT分析
    Summary Intercept Energy Services Inc. (Intercept Energy), formerly Global Green Matrix Corp., is an oilfield service provider. The company specializes in frac water heating, unconventional energy extraction and related services such as oilfield equipment, oil sands processing, and oilfield waste di …
  • Volta River Authority-エネルギー分野:企業M&A・提携分析
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. The authority produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. It procures energy from Takoradi International Company Ltd; an …
  • Mabuhay Vinyl Corp (MVC):企業の財務・戦略的SWOT分析
    Mabuhay Vinyl Corp (MVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • My Health Direct, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary My Health Direct, Inc. (MHD) is a healthcare technology company. The company provides web-based solutions for the management of healthcare appointments. It meets the enterprise needs of institutional healthcare clients and the standards of managed care plans, physician practices and health s …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company provides smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It of …
  • Abraxas Petroleum Corp (AXAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Permian basin …
  • Kancera AB (KAN):企業の財務・戦略的SWOT分析
    Summary Kancera AB (Kancera) is a developer of drug candidates for the treatment of cancer. The company’s pipeline products include fractalkine inhibitor AZD8797, used to stop tumor growth; small molecule HDAC6 inhibitors, for neutralizing blood cancer; small molecule PFKFB3 inhibitors, for stopping …
  • Eastman Chemical Company:企業の戦略・SWOT・財務分析
    Eastman Chemical Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Chemical Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ruchi Soya Industries Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ruchi Soya Industries Limited M …
  • VytronUS Inc:医療機器:M&Aディール及び事業提携情報
    Summary VytronUS Inc (VytronUS), formerly CardionUS Inc, is an independent clinical stage medical device company that develops technologies for the treatment atrial fibrillation and other cardiac arrhythmias. The company is developing a catheter-based imaging and ablation platform based on low-inten …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Comision Federal de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • IntriCon Corporation (IIN):企業の財務及び戦略的SWOT分析
    Summary IntriCon Corporation (IntriCon) is a medical device company that designs, develops and manufactures miniature and micro-miniature body worn electronic and medical devices. The company offers products such as glucose monitoring, cardiac monitoring, medical coils, plastic medical molding, ampl …
  • Interbulk Group PLC (INB):企業の財務及び戦略的SWOT分析
    Interbulk Group PLC (INB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Purplebricks Group plc :企業の戦略・SWOT・財務分析
    Purplebricks Group plc  - Strategy, SWOT and Corporate Finance Report Summary Purplebricks Group plc  - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BNY Mellon Wealth Management (BK):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "BNY Mellon Wealth Management" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stric …
  • Vakrangee Limited (VAKRANGEE):企業財務及び戦略的SWOT分析
    Summary Vakrangee Limited (Vakrangee) formerly Vakrangee Softwares Ltd. is a technology company that provides software and database related services. The company’s services include BFSI services, G2C services, B2C services, E-governance projects and strategic projects. It offers BFSI services includ …
  • Genta Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Genta Incorporated Mergers and …
  • Sumitomo Densetsu Co., Ltd. (1949):企業の財務及び戦略的SWOT分析
    Summary Sumitomo Densetsu Co., Ltd. (Sumitomo), a subsidiary of Sumitomo Electric Industries, Ltd is a construction company that develops electric facilities and others. The company’s services include electrical and air conditioning, renewal and maintenance, engineering, and information and communic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆